Home » Topics » BioWorld Science

BioWorld Science
RSS

Noven and Shire to proceed with further development of MethyPatch

June 18, 2004

Labopharm to apply polymeric nanodelivery systems technology to cancer drug

June 18, 2004

New phase III hemodialysis trial for ferumoxytol iron replacement therapy

June 18, 2004

Phase II trial of Xcytrin for recurrent low-grade NHL under way

June 18, 2004

Efaproxyn and Revaproxyn, new trade names for efaproxiral

June 18, 2004

Emisphere initiates new trial to select oral form of unfractionated heparin

June 18, 2004

OSI and Genentech sign new Tarceva agreements

June 18, 2004

Second phase III trial of phenserine for Alzheimer's disease

June 18, 2004

Sepracor resubmits Estorra NDA

June 18, 2004

FDA approves Rapinex powder for oral suspension 20 mg

June 18, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...